Remedial Health vs Andson Biotech
Side-by-side comparison of AI visibility scores, market position, and capabilities
Lagos B2B pharmaceutical marketplace connecting 5,000+ African pharmacies to GSK/Pfizer/AstraZeneca with 24-hour delivery and inventory financing; $12M QED Investors Series A with 7x revenue growth.
About
Remedial Health is a Lagos-based B2B health technology company digitizing pharmaceutical procurement for African pharmacies and hospitals — operating an e-commerce marketplace connecting 5,000+ pharmacies and healthcare facilities with 300+ pharmaceutical manufacturers including GSK, Pfizer, and AstraZeneca, providing access to 8,000+ SKUs, 24-hour delivery across Nigeria, and inventory financing that enables pharmacies to stock products without full upfront capital. Founded in 2021 and backed with $16.4 million raised including a $12 million Series A led by QED Investors in March 2024, Remedial Health achieved 7x revenue growth in 10 months while tripling its client base since late 2023.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
About
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.